Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

253.29
-1.5200-0.60%
Pre-market: 250.01-3.2800-1.29%08:21 EDT
Volume:363.77K
Turnover:92.70M
Market Cap:16.77B
PE:19.38
High:257.89
Open:253.62
Low:252.87
Close:254.81
52wk High:282.15
52wk Low:186.05
Shares:66.19M
Float Shares:65.54M
Volume Ratio:0.65
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):13.07
EPS(LYR):-4.4176
ROE:118.78%
ROA:9.58%
PB:10.00
PE(LYR):-57.34

Loading ...

Ascendis Pharma Director Jean-Jacques Bienaime Buys USD 492,079 of Common Shares

Reuters
·
Aug 19

Eyconis Announces Initiation of First-in-Human Clinical Trial of Eyc-0305 in Treatment-NaÏVe Wet Age-Related Macular Degeneration Patients

THOMSON REUTERS
·
Aug 18

Ascendis Pharma A/S Just Recorded A 104% EPS Beat: Here's What Analysts Are Forecasting Next

Simply Wall St.
·
Aug 16

Ascendis Pharma Reports Solid Yorvipath Quarter; Yuviwel Off to Strong Start, RBC Says

MT Newswires Live
·
Aug 14

Ascendis Pharma is Maintained at Overweight by Barclays

Dow Jones
·
Aug 14

Ascendis Pharma (ASND) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
Aug 14

RBC Adjusts PT on Ascendis Pharma to $290 From $280, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 14

Ascendis Pharma (ASND) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Ascendis Pharma a/S : Jefferies Raises Target Price to $333 from $325

THOMSON REUTERS
·
Aug 14

Analysts Are Bullish on These Healthcare Stocks: ProMIS Neurosciences (PMN), Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Ascendis Pharma's Long-Term Potential Intact, Wedbush Says

MT Newswires Live
·
Aug 14

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Ascendis Pharma A/S Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Pre-Bell Thursday

MT Newswires Live
·
Aug 13

Ascendis Pharma's Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 13

Earnings Flash (ASND) Ascendis Pharma Posts Q2 Non-IFRS EPS 0.90 Euros, vs. FactSet Est of 1.80 Euros

MT Newswires Live
·
Aug 13

Ascendis Pharma Q2 Revenue EUR 339.3 Million

THOMSON REUTERS
·
Aug 13

Ascendis Pharma Q2 FY26 Swings to Net Profit of €207 Million; Revenue More than Doubles to €339 Million

Reuters
·
Aug 13

Ascendis Pharma Q2 Adj. EPS $1.05 Beats $0.78 Estimate, Sales $394.437M Beat $353.800M Estimate

Benzinga Earnings
·
Aug 13